Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.

This study indicates that these models may be useful for further investigation of the CB2 receptor as a target for anti-inflammatory disease modification in Parkinson's disease. PMID: 27317300 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27317300?dopt=Abstract

Source: Experimental Neurology - June 13, 2016 Category: Neurology Authors: Concannon RM, Okine BN, Finn DP, Dowd E Tags: Exp Neurol Source Type: research